DR. WOLFGANG H DILLMAN, M.D.
Osteopathic Medicine at Arbor Dr, San Diego, CA
License number
California A33658
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California A33658
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
2
200 W Arbor Dr, San Diego, CA 92103
9500 Gilman Drive #0618, La Jolla, CA 92093
9500 Gilman Drive #0618, La Jolla, CA 92093
Phone
(858) 534-9934
(858) 534-9932 (Fax)
(858) 534-9932 (Fax)
Personal information
See more information about WOLFGANG H DILLMAN at radaris.comName
Address
Phone
355 S Nardo Ave, Solana Beach, CA 92075
Del Mar, CA
355 Nardo Ave, Solana Beach, CA 92075
Professional information
Wolfgang Heinrich Dillman, San Diego CA
Specialties:
Internal Medicine, Endocrinology and Metabolism, Endocrinology, Diabetes & Metabolism
Work:
Va San Diego Healthcare System
3350 La Jolla Village Dr, San Diego, CA 92161 Ucsd Medical Group
9350 Campus Point Dr, La Jolla, CA 92037 UC San Diego Health System
200 W Arbor Dr, San Diego, CA 92103
3350 La Jolla Village Dr, San Diego, CA 92161 Ucsd Medical Group
9350 Campus Point Dr, La Jolla, CA 92037 UC San Diego Health System
200 W Arbor Dr, San Diego, CA 92103
Education:
Ludwig-Maximilians-Universitaet Munchen (1970)
Dr. Wolfgang H Dillman, San Diego CA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
200 W Arbor Dr, San Diego 92103
(858) 534-9934 (Phone)
UCSD DEPT OF MEDICINE
9500 Gilman Dr, La Jolla 92093
(858) 534-9934 (Phone), (858) 534-9932 (Fax)
(858) 534-9934 (Phone)
UCSD DEPT OF MEDICINE
9500 Gilman Dr, La Jolla 92093
(858) 534-9934 (Phone), (858) 534-9932 (Fax)
Certifications:
Diabetes, Metabolism & Endocrinology, 1977, Internal Medicine, 1973
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
200 W Arbor Dr, San Diego 92103
UCSD DEPT OF MEDICINE
9500 Gilman Dr, La Jolla 92093
UCSD Medical Center - Hillcrest
200 West Arbor Dr, San Diego 92103
UCSD DEPT OF MEDICINE
9500 Gilman Dr, La Jolla 92093
UCSD Medical Center - Hillcrest
200 West Arbor Dr, San Diego 92103
Education:
Medical School
Ludwig Maximiliams University / Medical Faculty
City Hosp-Mt Sinai Hosp
Montefiore Hosp-Albert Einstein Coll Med
Montefiore Hosp
Ludwig Maximiliams University / Medical Faculty
City Hosp-Mt Sinai Hosp
Montefiore Hosp-Albert Einstein Coll Med
Montefiore Hosp
Method For Inhibition Of Phospholamban Activity For The Treatment Of Cardiac Disease And Heart Failure
US Patent:
2009014, Jun 11, 2009
Filed:
Oct 23, 2008
Appl. No.:
12/257329
Inventors:
KENNETH CHIEN - LA JOLLA CA, US
WOLFGANG DILLMAN - LA JOLLA CA, US
SUSUMU MINAMISAWA - LA JOLLA CA, US
HUAPING HE - LA JOLLA CA, US
MASAHIKO HOSHIJIMA - LA JOLLA CA, US
MARKUS MEYER - LA JOLLA CA, US
CHRISTOPHER SCOTT - SAN DIEGO CA, US
YIBIN WANG - LA JOLLA CA, US
GREGG J. SILVERMAN - LA JOLLA CA, US
WOLFGANG DILLMAN - LA JOLLA CA, US
SUSUMU MINAMISAWA - LA JOLLA CA, US
HUAPING HE - LA JOLLA CA, US
MASAHIKO HOSHIJIMA - LA JOLLA CA, US
MARKUS MEYER - LA JOLLA CA, US
CHRISTOPHER SCOTT - SAN DIEGO CA, US
YIBIN WANG - LA JOLLA CA, US
GREGG J. SILVERMAN - LA JOLLA CA, US
International Classification:
A61K 31/7088, A61P 9/00
US Classification:
514 44
Abstract:
The present invention provides a method for the treatment of heart failure through the use of small peptide complexes and recombinant proteins which function to enhance contractility in failing hearts and reduce blood pressure in individuals with hypertension by inhibiting the interaction between phospholamban and sacroplasmic reticulum Ca ATPase (SERCA2a) within cardiomyocytes. In addition, a means is provided for the transport of such therapeutic agents into the cytoplasm and nucleus of cardiomyocytes.
Method For Inhibition Of Phospholamban Activity For The Treatment Of Cardiac Disease And Heart Failure
US Patent:
2004012, Jun 24, 2004
Filed:
Nov 10, 2003
Appl. No.:
10/705791
Inventors:
Kenneth Chien - La Jolla CA, US
Wolfgang Dillman - La Jolla CA, US
Susumu Minamisawa - La Jolla CA, US
Huaping He - La Jolla CA, US
Masahiko Hoshijima - La Jolla CA, US
Markus Meyer - La Jolla CA, US
Christopher Scott - San Diego CA, US
Yibin Wang - La Jolla CA, US
Gregg Silverman - La Jolla CA, US
Wolfgang Dillman - La Jolla CA, US
Susumu Minamisawa - La Jolla CA, US
Huaping He - La Jolla CA, US
Masahiko Hoshijima - La Jolla CA, US
Markus Meyer - La Jolla CA, US
Christopher Scott - San Diego CA, US
Yibin Wang - La Jolla CA, US
Gregg Silverman - La Jolla CA, US
International Classification:
A61K038/17, A61K048/00, A61K039/395
US Classification:
514/007000, 514/044000, 424/130100
Abstract:
The present invention provides a method for the treatment of heart failure through the use of small peptide complexes and recombinant proteins which function to enhance contractility in failing hearts and reduce blood pressure in individuals with hypertension by inhibiting the interaction between phospholamban and sarcoplasmic reticulum Ca ATPase (SERCA2a) within cardiomyocytes. In addition, a means is provided for the transport of such therapeutic agents into the cytoplasm and nucleus of cardiomyocytes.